4th Quarter - Report

ASCENSION HEALTH ALLIANCE D/B/A ASCENSION for ASCENSION HEALTH ALLIANCE D/B/A ASCENSION

Firm
Client
Income
—
Expenses
$290,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Religion REL

Religious freedom and conscience protection.

LobbyistCovered position, as disclosed
MARK HAYES —
BROCK INGMIRE —
PETER LEIBOLD —
DANIELLE WHITE —

Contacted: SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Drug Enforcement Administration (DEA); Office of Management & Budget (OMB); Vice President of the U.S.; HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA)

Veterans VET

Implementation of the Mission Act

LobbyistCovered position, as disclosed
MARK HAYES —
BROCK INGMIRE —
PETER LEIBOLD —
JOSEPH LUSTIG New —
DANIELLE WHITE —

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); Vice President of the U.S.; Drug Enforcement Administration (DEA); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES

Health Issues HCR

Affordable prescription drugs, 340B Program; HR985 FAST Generics Act of 2019; Appropriate and accurate payment for healthcare; Site Neutral payment policies; S. 1895 - Lower Health Care Costs Act; S. 340 - CREATES Act, H.R. 987 - Strengthening Health Care and Lowering Prescription Drug Costs Act; S. 1391 - Fair Accountability and Innovative Research Drug Pricing Act of 2019; Surprise billing: S. 1531 - Stop the Outrageous Practice of Surprise Medical Bills Act of 2019; HR 3, the Lower Drug Costs Now Act; H.R.2149 - Exposing the Financing of Human Trafficking Act; H.R.508 - Trafficking Victims Housing Act of 2019; H.R. 1520 - Purple Book Continuity At of 2019; H.R. 1503 - Orange Book Transparency Act of 2019; S.2543 - Prescription Drug Pricing Reduction Act of 2019; Health care privacy; patient privacy; H.R. 647, S.2080 - Palliative Care and Hospice Education and Training Act; Conrad 30 and the Physician Access Reauthorization Act, S 948; Issues related to the Medicaid Fiscal Accountability Regulation (MFAR); HR 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act; HR 6201 - Families First Coronavirus Response Act - Public Law No: 116-127; HR 748 - Coronavirus Aid, Relief, and Economic Security (CARES) Act; response to the COVID-19 public health emergency; S. 178 - HEALS Act; H.R. 1425, Patient Protection and Affordable Care Enhancement Act; H.R. 6800 - HEROES Act; H.R. 266, Paycheck Protection Program and Health Care Enhancement Act; issues related to coverage of virtual car; Financial support for providers for diagnosis and treatment related to COVID-19, coverage of COVID-19 related conditions, and access to PPE and other materials and equipment related to the treatment of patients with COVID-19; H.R. 133 - Consolidated Appropriations Act; Issues related to social determinants of health; H.R. 6561 - Improving Social Determinants of Health Act ; S. 4421- Temporary Reciprocity to Ensure Access to Treatment Act; liability relief for health care providers

LobbyistCovered position, as disclosed
MARK HAYES —
BROCK INGMIRE —
PETER LEIBOLD —
JOSEPH LUSTIG New —
DANIELLE WHITE —

Contacted: Drug Enforcement Administration (DEA); SENATE; Vice President of the U.S.; HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); Office of Management & Budget (OMB); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: H.R. 1520 (116th), H.R. 133 (116th), S. 4421 (116th), S. 2543 (116th), S. 1531 (116th), S. 1895 (116th), H.R. 1425 (116th), H.R. 3 (116th), H.R. 6800 (116th), H.R. 266 (116th), H.R. 6074 (116th), H.R. 508 (116th), H.R. 6561 (116th), H.R. 1503 (116th), H.R. 748 (116th), H.R. 987 (116th), S. 1391 (116th), S. 2080 (116th), H.R. 985 (116th), H.R. 2149 (116th), S. 340 (116th), S. 178 (116th), H.R. 6201 (116th), H.R. 647 (116th)

Medicare/Medicaid MMM

Site Neutral payment policies; Medicare for All, Medicare Buy In; Affordable prescription drugs; Medicaid DSH; Medicare bad debt; wage index; modernization of the Stark Law and Anti-Kickback statutes; H.R. 3 - Lower Drug Costs Now Act of 2019; S.2543 - Prescription Drug Pricing Reduction Act of 2019; Issues related to the Medicaid Fiscal Accountability Regulation (MFAR); HR 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act; HR 6201 - Families First Coronavirus Response Act; HR 748 - Coronavirus Aid, Relief, and Economic Security (CARES) Act; response to the COVID-19 public health emergency; S. 178 - HEALS Act; H.R. 1425, Patient Protection and Affordable Care Enhancement Act; H.R. 6800 - HEROES Act; H.R. 266, Paycheck Protection Program and Health Care Enhancement Act; issues related to coverage of virtual care under Medicare and Medicaid; Financial support for providers for diagnosis and treatment related to COVID-19, coverage of COVID-19 related conditions, and access to PPE and other materials and equipment related to the treatment of patients with COVID-19; H.R. 133 - Consolidated Appropriations Act; Issues related to social determinants of health; Medicare sequestration relief; issues related to payments for physicians under the Physician Fee Schedule; Issues related to supporting Childrens Hospitals

LobbyistCovered position, as disclosed
MARK HAYES —
BROCK INGMIRE —
PETER LEIBOLD —
JOSEPH LUSTIG New —
DANIELLE WHITE —

Contacted: Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA); Vice President of the U.S.; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: S. 2543 (116th), H.R. 6201 (116th), H.R. 6800 (116th), H.R. 266 (116th), H.R. 748 (116th), S. 178 (116th), H.R. 6074 (116th), H.R. 1425 (116th), H.R. 133 (116th), H.R. 3 (116th)

Immigration IMM

Supported maintaining the current definition of Public Charge to ensure continued access to Medicaid and other federal assistance programs; Conrad 30 and the Physician Access Reauthorization Act, S 948

LobbyistCovered position, as disclosed
MARK HAYES —
BROCK INGMIRE —
PETER LEIBOLD —
JOSEPH LUSTIG New —
DANIELLE WHITE —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); Centers For Medicare and Medicaid Services (CMS); Vice President of the U.S.; SENATE; Drug Enforcement Administration (DEA); Food & Drug Administration (FDA); Office of Management & Budget (OMB)

Pharmacy PHA

Affordable prescription drugs, 340B program, drug shortages; S. 1895 - Lower Health Care Costs Act; HR 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act; HR 6201 - Families First Coronavirus Response Act; HR 748 - Coronavirus Aid, Relief, and Economic Security (CARES) Act; response to the COVID-19 public health emergency, access to PPE and medications related to treatment of patients with COVID-19; S. 178 - HEALS Act; H.R. 1425, Patient Protection and Affordable Care Enhancement Act; H.R. 6800 - HEROES Act; Financial support for providers for diagnosis and treatment related to COVID-19, coverage of COVID-19 related conditions, and access to PPE and other materials and equipment related to the treatment of patients with COVID-19; H.R. 133 - Consolidated Appropriations Act; Issues related to social determinants of health; Support for Community Health Centers

LobbyistCovered position, as disclosed
MARK HAYES —
BROCK INGMIRE —
PETER LEIBOLD —
JOSEPH LUSTIG New —
DANIELLE WHITE —

Contacted: Vice President of the U.S.; HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); SENATE; Centers For Medicare and Medicaid Services (CMS); Drug Enforcement Administration (DEA); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Food & Drug Administration (FDA)

Bills named: S. 178 (116th), H.R. 1425 (116th), H.R. 133 (116th), H.R. 6074 (116th), H.R. 6201 (116th), S. 1895 (116th), H.R. 6800 (116th), H.R. 748 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.